Jupiter Neurosciences, Inc.
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.2274 USD
−2.44 M USD
0.00 USD
14.68 M
About Jupiter Neurosciences, Inc.
Sector
Industry
CEO
Christer Rosén
Website
Headquarters
Jupiter
IPO date
Dec 3, 2024
Identifiers
3
ISIN US48208B2034
Jupiter Neurosciences, Inc. is a clinical-stage pharmaceutical company engaged in treating neuroinflammation with a current focus on CNS disorders and rare diseases. The firm offers JOTROL, an enhanced orally administered resveratrol formulation, designed to deliver therapeutically relevant, safe levels of resveratrol. The company was founded by Christer Rosén, Alexander Rosén, Claes Wahlestedt, Marshall Hayward, and Shaun P. Brothers in January 2016 and is headquartered in Jupiter, FL.
Related stocks
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of JUNS is 0.5779 USD — it has decreased by −0.19% in the past 24 hours. Watch Jupiter Neurosciences, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Jupiter Neurosciences, Inc. stocks are traded under the ticker JUNS.
JUNS stock has fallen by −3.23% compared to the previous week, the month change is a −37.86% fall, over the last year Jupiter Neurosciences, Inc. has showed a −35.40% decrease.
JUNS reached its all-time high on Dec 19, 2024 with the price of 19.5100 USD, and its all-time low was 0.4800 USD and was reached on Jan 30, 2026. View more price dynamics on JUNS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
JUNS stock is 5.27% volatile and has beta coefficient of 1.03. Track Jupiter Neurosciences, Inc. stock price on the chart and check out the list of the most volatile stocks — is Jupiter Neurosciences, Inc. there?
Today Jupiter Neurosciences, Inc. has the market capitalization of 19.89 M, it has increased by 8.59% over the last week.
Yes, you can track Jupiter Neurosciences, Inc. financials in yearly and quarterly reports right on TradingView.
Jupiter Neurosciences, Inc. is going to release the next earnings report on Feb 25, 2026. Keep track of upcoming events with our Earnings Calendar.
JUNS net income for the last quarter is −2.29 M USD, while the quarter before that showed −2.25 M USD of net income which accounts for −1.56% change. Track more Jupiter Neurosciences, Inc. financial stats to get the full picture.
No, JUNS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Feb 15, 2026, the company has 4 employees. See our rating of the largest employees — is Jupiter Neurosciences, Inc. on this list?
Like other stocks, JUNS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Jupiter Neurosciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Jupiter Neurosciences, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Jupiter Neurosciences, Inc. stock shows the sell signal. See more of Jupiter Neurosciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.